EP. 1: Cardiometabolic Risk: Treating the Whole Patient
EP. 2: Raising the Bar on Reducing Cardiometabolic Risk
EP. 3: Lifestyle Modifications to Reduce Cardiometabolic Risk
EP. 4: Stratification for Cardiometabolic Risk Reduction
EP. 5: Setting Targets for Lowering Cardiometabolic Risk
EP. 6: Choosing Among Antidiabetes Agents
EP. 7: Understanding Cardiovascular Outcomes Trials
EP. 8: Cardiovascular Benefits with SGLT2 Inhibition: EMPA-REG
EP. 9: Current CV Evidence Across SGLT2 Inhibitors
EP. 10: Examining CV Evidence with Antidiabetes Medications
EP. 11: Changing Treatment: Established Cardiovascular Disease
EP. 12: Primary CV Prevention and Prediabetes
EP. 13: Paradigm Shift in Cardiometabolic Diseases
EP. 14: Improving Care by Increasing the Cardiometabolic Focus
